Validation of the ACAS TIA/stroke algorithm

被引:28
|
作者
Karanjia, PN
Nelson, JJ
Lefkowitz, DS
Dick, AR
Toole, JF
Chambless, LE
Hayes, R
Howard, VJ
机构
[1] MARSHFIELD CLIN FDN MED RES & EDUC, DEPT NEUROL, MARSHFIELD, WI 54449 USA
[2] UNIV N CAROLINA, DEPT BIOSTAT, CHAPEL HILL, NC USA
[3] UNIV KANSAS, MED CTR, DEPT NEUROL, KANSAS CITY, KS 66103 USA
关键词
D O I
10.1212/WNL.48.2.346
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: An easily administered questionnaire and algorithm classifying transient ischemic attacks (TIAs) or strokes, and also their distribution, could be invaluable for identifying endpoints in epidemiologic studies or clinical trials of prevention and therapy of cerebral ischemia. The Asymptomatic Carotid Atherosclerosis Study (ACAS) devised a symptom-based questionnaire and algorithm for detecting events in the trial. The purpose of this study was to determine sensitivity, specificity, and agreement rates of the questionnaire and algorithm against diagnoses of a panel of cerebrovascular disease authorities. Methods: Three hundred eighty-one men and women at eight medical centers reported symptoms of stroke, TIA, or other neurologic illness. The questionnaire Mas administered by trained interviewers and the responses were analyzed using the algorithm. A standardized neurologic Examination was performed by a neurologist. Data were submitted to two or more external reviewers, Sensitivity, specificity, and the kappa statistic (k) were used to evaluate the relationship between the algorithm and the external reviewers' diagnosis. Results: Of the 381 reviews: 196 were diagnosed as TIA or stroke by the external panel. The algorithm's agreement with the diagnosis of TIA or stroke was 80.1%, and kappa was 0.60. Sensitivity was 87.8%, and specificity was 71.9%. Conclusion: While statistical agreement rates depend on the method of sample selection, the algorithm has a high agreement with an external panel of experts and is a sensitive tool for event detection. The lower specificity indicates that careful neurologic evaluation may be required to confirm or refute events identified by the screening algorithm.
引用
收藏
页码:346 / 351
页数:6
相关论文
共 50 条
  • [41] Sekundärprävention nach TIA oder ischämischem SchlaganfallSecondary stroke prevention after TIA or ischemic stroke
    Hans Christoph Diener
    Georg Nickenig
    Herz, 2021, 46 (3) : 293 - 302
  • [42] PREDICTING RISK OF STROKE FOLLOWING TIA: A SYSTEMATIC REVIEW OF THE VALIDATION OF ABCD2 CLINICAL PREDICTION RULE
    Galvin, R.
    Geraghty, C.
    Motterlini, N.
    Dimitrov, B. D.
    Fahey, T.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2010, 64 : A18 - A18
  • [43] Validation of a 4-point prediction rule to stratify short-term stroke risk after TIA
    Johnston, SC
    Sidney, S
    STROKE, 2005, 36 (02) : 430 - 430
  • [44] Microalbuminuria in the acute phase of ischemic stroke and TIA
    Debiais, S.
    Bonnaud, I.
    Saudeau, D.
    Halimi, J. M.
    de Toffol, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 102 - 102
  • [45] Identification and management of difficult stroke and TIA syndromes
    Brown, MM
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 : I17 - I22
  • [46] Metabolic syndrome and ischemic Stroke/TIA: Is there a relationship?
    Mikesell, Tim
    Gilski, Donna
    Chokshi, Dipal
    Shah, Neil
    NEUROLOGY, 2008, 70 (11) : A196 - A196
  • [47] TIA AND STROKE CAUSED BY CEREBROVASCULAR TONE INSTABILITY
    FRIBERG, L
    OLSEN, TS
    LASSEN, NA
    UPSALA JOURNAL OF MEDICAL SCIENCES, 1986, : 27 - 27
  • [48] Evaluation of costs and outcome in cardioembolic stroke or TIA
    Yaroslav Winter
    Caroline Wolfram
    Matthias Schaeg
    Jens-Peter Reese
    Wolfgang H. Oertel
    Richard Dodel
    Tobias Back
    Journal of Neurology, 2009, 256 : 954 - 963
  • [49] Antiplatelet Therapy after Ischemic Stroke or TIA
    Grotta, James C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (03): : 291 - 292
  • [50] Extending Dual Antiplatelet Therapy for TIA or Stroke
    Kim, Anthony S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (26): : 2478 - 2479